Plasma concentration of cytokine antagonists in patients with HIV infection

NeuroImmunoModulation

Volumn 1, Issue 1, 1994, Pages 42-49

  Catania, Anna ^a   Manfredi, Maria G ^a   Airaghi, Lorena ^a   Vivirito, Maria C ^b   Capetti, Amedeo ^b   Milazzo, Francesco ^b   Lipton, James M ^c   Zanussi, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Sacco   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

AIDS; HIV infection; Interleukin 1 receptor antagonist; Soluble tumor necrosis factor receptor; Melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD; DRUG ANTAGONISM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; METABOLISM; MIDDLE AGED;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADRENOCORTICOTROPIC HORMONE; ADULT; ALPHA-MSH; CYTOKINES; FEMALE; HIV; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0028366799     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097089     Document Type: Article

References (42)

1. Rosenberg ZF, Fauci AS: Immunopathogenesis of HIV infection. FASEB J 1191;5:2382-2390.
2. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. iN Engl J Med 1993;328:327-335.
3. Lipton JM: Modulation of host defence by the neuropeptide a-MSH. Yale J Biol Med 1990;63:173-182.
4. Lipton JM, Catania A: α-MSH peptides modulate fever and inflammation; in Bartfai T, Ottoson D (eds): Proceedings of the International Wenner-Gren Center Symposium on Ncuro-Immunology of Fever. New York, Pergamon, 1992, pp 123-136.
5. Catania A, Lipton JM: α-MSH peptides in host responses: From basic evidence to human research. Ann NY Acad Sei 1993;680:412-424.
6. Catania A, Lipton JM: a-Melanocyle stimulating hormone in the modulation of host reactions. Endocr Rev, in press.
7. Murphy MT, Richards DB, Lipton JM: Antipyretic potency of centrally administered a- melanocyte stimulating hormone. Science 1983;221:192-193.
8. Hiltz ME, Catania A, Lipton JM: a-MSH peptides inhibit acute inflammation induced in mice by rIL-Iβ. rIL-6. rTNFα and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 1992;4:320-328.
9. Martin LW, Catania A, Hiltz ME, Lipton JM: Neuropeptide α-MSH antagonizes IL-6- and TNF-induced fever. Peptides 1991;12:297-299.
10. Robertson BA, Gahring LC, Daynes RA: Neuropeptides regulation of interleukin-1 activities. Capacity of α-melanocyte stimulating hormone to inhibit interleukin-1 inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 1986;10:371-385.
11. Martin LW, Deeter LB, Lipton JM: Acute phase response to endogenous pyrogen in rabbit: Effects of age and route of administration. Am J Physiol 1989;257:R 189-R193.
12. Martin LW, Lipton JM: Acute phase response to endotoxin: Rise in plasma α-MSH and effects of a-MSH injection. Am J Physiol 1990;259:R768-R772.
13. Catania A, Martin LW, Lipton JM: Dexamethasone facilitates α-MSH release in the rabbit. Brain Res Bull 1991;26:727-730.
14. Catania A, Suffredini AF, Lipton JM: α-MSH response to endotoxin in normal human subjects. FASEB J 1991;5:A 1392.
15. Catania A, Airaghi L, Manfredi MG, Vivirito MC, Milazzo F, Lipton JM, Zanussi C: Proopiomelanocortin-derived peptides and cytokines: Relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1993;66:73-79.
16. Dinarello CA, Thompson RC: Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991;12:405-410.
17. Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990;85:1694-1697.
18. Granowitz EV, Clark BD, Vannier E, Callahan MV, Dinarello CA: Effect of interleukin-1 IL-ljblockade on cytokine synthesis: 1. IL-1 receptor antagonist inhibits IL-l-induccd cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 1992;79:2356-2363.
19. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, WolffSM, Dinarello CA: Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991;338:1423-1424.
20. Seckinger P, Isaaz S, Dayer JM: Purification and biologic characterization of a specific tumor necrosis factor α inhibitor. J Biol Chem 1989;264:11966-11973.
21. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach DA: A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-11980.
22. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-4849.
23. Bateman A, Singh A, Kral T, Solomon S: The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989;10:92-112.
24. Catania A, Manfredi MG, Airaghi L, Vivirito MC, Milazzo F, Zanussi C: Evidence for an impairment of the immune-adrenal circuit in patients with acquired immunodeficiency syndrome. Horm Metab Res 1990;22:597-598.
25. Catania A, Manfredi MG, Airaghi L, Vivirito MC, Milazzo F, Lipton JM, Zanussi C: Delayed cortisol response to antigenic challenge in patients with acquired immunodeficiency syndrome. Ann NY Acad Sci 1992;650:202-204.
26. Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990;322:166-172.
27. Bird AG: Clinical and immunological assessment of HIV infection. J Clin Pathol 1992;45:850-854.
28. Fuchs D, Hausen A, Rcibnegger D, Werner ER. Dierich MP, Wachter H: Ncopterin as a marker for activated cell-mediated immunity: Application in HIV infection. Immunol Today 1988;9:150-155.
29. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR 17): 1-19.
30. Centers for Disease Control: Revision of the case definition for acquired immunodeficiency syndrome. MMWR 1987;36(1S):3S-15S.
31. Dinarello CA: Was the original endogenous pyrogen interleukin-1?: in Bom ford C. Henderson C (ed): Interleukin-1. Inflammation and Disease. New York, Elsevier. 1989, pp 17-28.
32. Sundar SK, Cierpial MA, Kamaraju LS, Long S. Hsieh S, Lorenz C, Aaron M, Ritchie JC, Weiss JM: Human immunodeficiency virus glycoprotein (gp 120) infused into rat brain induces interleukin-1 to elevate pituitary-adrenal activity and decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 1991;88:11246-11250.
33. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DF.: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-360.
34. Kalinkovich A, Engelmann H. Harpaz N, Bur-Stein R, Barak V, Kalickman I, Wallach D, Bentwich Z: Elevated scrum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992;89:351-355.
35. Samson WK, Lipton JM, Zimmer JA: The cffect of fever on central α -MSH concentrations in the rabbit. Peptides 1981;2:419-423.
36. Bell RC, Lipton JM: Pulsatile release of antipyretic neuropeptide α-MSH from septum of rabbit during fever. Am J Physiol 1987;252:R1152-R1157.
37. Dao TK, Bell RC, Feng J, Jameson DM, Lipton JM: C-reactive protein. leukocytes, and fever after central IL-1 and u-MSH in aged rabbits. Am J Physiol 1988;254:R401-R409.
38. Lipton JM, Macaluso A, Hiltz ME, Catania A: Central administration of the peptide α -MSH inhibits inflammation in the skin. Peptides 1991;12:795-798.
39. Sundar SK, Becker KJ, Cierpial MA, Carpenter MD, Rankin LA, Flccncr SL, Ritchie JC, Simson PE, Weiss JM: Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 1989;86:6398-6402.
40. Weiss JM, Sundar SK, Cierpial MA, Ritchie JC: Effccts of interleukin-l infused into brain arc antagonized by α -MSH in a dosc-dcpcndent manner. Eur J Pharmacol 1991;192:177-179.
41. Tapper ML, Rotterdam HZ, Lerner CW, Al’Khafaji K, Seitzman PA: Adrenal necrosis in the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:239-241.
42. Verges B, Chavanet P, Dcsgrcs J, Vaillant G, Waldner A. Brun JM, Putelal R: Adrenal function of HIV infected patients. Acta Endocrinol 1989;121:633-637.